We endeavor to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence, or AI, in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. We make tests intelligent by connecting laboratory results to a patient’s own clinical data, thereby personalizing the results. Our novel insight was realizing that all laboratory test results, genomic or otherwise, could be contextualized for a specific patient based upon that patient’s uniquecharacteristics, and technology could therefore guide therapy selection and treatment decisions to allow each patient to progress on their own unique path.The drugs recommended, the clinical trials explored, the care pathways evaluated, the adverse events considered—all have the potential to be refined and enhanced when test results are connected to a patient’s personal profile, enabling the right patient to be routed to the right therapy at the right time.
Lead Underwriter
Allen & Company LLC,J.P. Morgan Securities LLC,Morgan Stanley & Co. LLC
Co-Managers
BofA Securities, Inc,Loop Capital Markets, LLC,Needham & Company, LLC,Stifel Nicolaus & Company, Incorporated,TD Securities (USA) LLC,William Blair & Company, L.L.C.
